InvestorsObserver is giving Arena Pharmaceuticals, Inc. (ARNA) an Analyst Rating Rank of 14, meaning ARNA is ranked higher by analysts than 14% of stocks. The average price target for ARNA is $93.875 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating ARNA a Buy today. Find out what this means to you and get the rest of the rankings on ARNA!